X0508 4 2025-03-06 false 0001770121 Sana Biotechnology, Inc. SANA 0001568605 Wyrick Susan D. C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 false true false false See Remarks false Common Stock 2025-03-07 4 M false 3250.00 0.00 A 158231.00 D Common Stock 2025-03-10 4 F false 836.00 2.56 D 157395.00 D Restricted Stock Units 2025-03-06 4 A false 41667.00 0.00 A Common Stock 41667.00 41667.00 D Stock Option (Right to Buy) 2.55 2025-03-06 4 A false 187500.00 0.00 A 2035-03-05 Common Stock 187500.00 187500.00 D Restricted Stock Units 2025-03-07 4 M false 3250.00 0.00 D Common Stock 3250.00 9750.00 D Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock. The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. The option vests and becomes exercisable as to 25% of the underlying shares on March 6, 2026 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. Acting Chief Financial Officer and Principal Accounting Officer /s/ Bernard J. Cassidy, Attorney-in-Fact for Susan D. Wyrick 2025-03-10